Antipsychotic utilisation and polypharmacy in Italian residential facilities: A survey

Epidemiology and Psychiatric Sciences

Volumn 20, Issue 2, 2011, Pages 171-179

  Ghio, L ^a   Natta, W ^a   Gotelli, S ^a   Ferrannini, L ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Department of Mental Health ^*  (Italy)

Author keywords

antipsychotic; polypharmacy; residential facilities

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG UTILIZATION; FEMALE; HUMAN; INFORMATION PROCESSING; ITALY; LENGTH OF STAY; MALE; MENTAL DISEASE; MIDDLE AGED; POLYPHARMACY; PRESCRIPTION; RESIDENTIAL HOME; STATISTICS;

ADULT; ANTIPSYCHOTIC AGENTS; CHOLINERGIC ANTAGONISTS; DATA COLLECTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; ITALY; LENGTH OF STAY; MALE; MENTAL DISORDERS; MIDDLE AGED; POLYPHARMACY; RESIDENCE CHARACTERISTICS; RESIDENTIAL FACILITIES;

EID: 79960968593     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796011000242     Document Type: Review

References (32)

1. Alessi-Severini S, Biscontri RG, Collins DM, Kozyrskyj A, Sareen J, Enns MW (2008). Utilization and costs of antipsychotic agents: a Canadian population-based study, 1996-2006. Psychiatric Services 59, 547-553.
2. Barbui C, Ciuna A, Nosè M, Levi D, Andretta M, Patten SB, Amaddeo F, Tansella M (2005). Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison. European Archives of Psychiatry and Clinical Neuroscience 255, 136-142. (Pubitemid 40558605)
3. Barbui C, Nosè M, Mazzi MA, Thornicroft G, Schene A, Becker T, Bindman J, Leese M, Helm H, Koeter M, Weinmann S, Tansella M (2006). Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. International Clinical Psychopharmachology 21, 355-362. (Pubitemid 44498277)
4. Centorrino F, Cincotta SL, Talamo A, Fogarty KV, Guzzetta F, Saadeh MG, Salvatore P, Baldessarini RJ (2008). Hospital use of antipsychotic drugs: polytherapy. Comprehensive Psychiatry 49, 65-69. (Pubitemid 350183965)
5. Centorrino F, Eakin M, Bahk WM, Kelleher JP, Goren J, Salvatore P, Egli S, Baldessarini RJ (2002). Inpatient antipsychotic drug use in 1998, 1993, and 1989. American Journal of Psychiatry 159, 1932-1935. (Pubitemid 35283263)
6. Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ (2004). Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risk versus benefits. American Journal of Psychiatry 161, 700-706. (Pubitemid 38445515)
7. Diaz FJ, de Leon J (2002). Excessive antipsychotic dosing in 2 U.S. state hospitals. Journal of Clinical Psychiatry 63, 998-1003. (Pubitemid 35388058)
8. Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC (2004). Prevalence, trends, and factors associated with antipsychotic polypharmacy among medicaid-eligible schizophrenia patients, 1998-2000. Journal of Clinical Psychiatry 65, 1377-1388.
9. Johnsen E, Svingen GF, Jorgensen HA (2004). Practice regarding antipsychotic therapy: a cross-sectional survey in two Norwegian hospitals. Nordic Journal of Psychiatry 58, 313-317. (Pubitemid 39248343)
10. Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC (2007). Long-term antipsychotic polypharmacy in the VA Health system: patient characteristics and treatment patterns. Psychiatric Services 58, 489-495. (Pubitemid 46640639)
11. Lelliott P, Paton C, Harrington M, Okocha C, Sensky T, Duffett R (2002). The influence of patient variables on polypharmacy and combined high dose of antipsychotic drug prescribed for in-patients. Psychiatric Bulletin 26, 411-414. (Pubitemid 35331237)
12. Loosbrock DL, Zhao Z, Johnstone BM, Morris LS (2003). Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia. Journal of Mental Health Policy and Economics 6, 67-75. (Pubitemid 37304742)
13. Mauri MC, Regispani F, Beraldo S, Volonteri LS, Ferrari VM, Fiorentini A, Invernizzi G (2005). Patterns of clinical use of antipsychotics in hospitalized psychiatric patients. Progress in Neuro-Psychopharmachology and Biological Psychiatry 29, 957-963. (Pubitemid 41080118)
14. McCue RE, Waheed R, Urcuyo L (2004). Polypharmacy in patients with schizophrenia. Journal of Clinical Psychiatry 64, 984-989. (Pubitemid 37158242)
15. Mojtabai R, Olfson M (2010). National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry 67, 26-36.
16. Paton C, Lelliott P, Harrington M, Okocha C, Sensky T, Duffett R (2003). Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. Journal of Psychopharmachology 17, 223-229. (Pubitemid 36753540)
17. Preti A, Rucci P, Gigantesco A, Santone G, Picardi A, Miglio R, de Girolamo G, PROGRES-Acute Group (2009). Patterns of care in patients discharged from acute psychiatric inpatient facilities. Social Psychiatry and Psychiatric Epidemiology 44, 767-776.
18. Ranceva N, Ashraf W, Odelola D (2010). Antipsychotic polypharmacy in outpatients at Birch Hill Hospital: incidence and adherence to guidelines. Journal of Clinical Pharmacology 50, 699-704.
19. Schorr SG, Loonen AJ, Brouwers JR, Taxis K (2008). A cross-sectional study of prescribing patterns in chronic psychiatric patients living in sheltered housing facilities. International Journal of Clinical Pharmacology and Therapeutics 46, 146-150. (Pubitemid 351721158)
20. Sernyak MJ, Rosenheck R (2004). Clinicians' reasons for antipsychotic coprescribing. Journal of Clinical Psychiatry 65, 1597-1600.
21. Sim K, Su A, Fujii S (2004). Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. British Journal of Clinical Pharmacology 58, 178-183. (Pubitemid 39043998)
22. Suzuki T, Uchida H, Tanaka KF, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H (2004). Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. International Journal of Neuropsychopharmacology 7, 1-10.
23. Tapp A, Wood AE, Secrest L, Erdmann J, Cubberley L, Kilzieh N (2003). Combination antipsychotic therapy in clinical practice. Psychiatric Services 54, 55-59. (Pubitemid 36043847)
24. Taylor D, Paton C, Kerwin R (2007). The Maudsley Prescribing Guidelines, 9th edn., Informa Healthcare: London.
25. Tempier RP, Pawliuk NH (2003) Conventional, atypical and combination antipsychotic prescriptions: a 2-year comparison. Journal of Clinical Psychiatry 64, 673-679. (Pubitemid 36750145)
26. Tibaldi G, Munizza C, Bollini P, Pirfo E, Punzo F, Gramaglia F (1997). Utilization of neuroleptic drugs in Italian Mental Health Services: a survey in Piedmont. Psychiatric Services 48, 213-217. (Pubitemid 27057405)
27. Tomasi R, de Girolamo G, Santone G, Picardi A, Micciolo R, Semisa D, Fava S, PROGRES Group (2006). The prescription of psychotropic drugs in psychiatric residential facilities: a national survey in Italy. Acta Psychiatrica Scandinavica 113, 212-223. (Pubitemid 43340874)
28. Verdoux H, Tournier M, Begaud B (2009). Pharmacoepidemiology of psychotropic drugs: examples of research challenges on major public health issues. Epidemiologia e Psichiatria Sociale 18, 107-113.
29. Veronese A, Vivenza V, Nosè M, Cipriani A, Tansella M, Barbui C (2008). Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach. Epidemiologia e Psichiatria sociale 17, 236-241.
30. Waddington JL, Youssef HA, Kinsella A (1998). Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-years prospective study. British Journal of Psychiatry 173, 325-329. (Pubitemid 28454819)
31. Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S (2000). Patients with schizophrenia at risk for excessive antipsychotic dosing. Journal of Clinical Psychiatry 61, 344-348. (Pubitemid 30345935)
32. Woods SW (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667. (Pubitemid 36750143)